RSS

epilepsy

In this online exclusive, Erik Janssen, vice president of Global New Patient Solutions Neurology at UCB, talks about why advancements in big data and analytics might be the key to helping patients with epilepsy. more

Opinion

The Medicines and Healthcare products Regulatory Agency (MHRA) has implemented changes to the licence for valproate medicines — Epilim, Depakote and generics used to treat epilepsy and bipolar disorder — in the interest of public safety. more

News

The US Food and Drug Administration (FDA) has granted orphan drug designation to Crossject's treatment for status epilepticus (epileptic seizure lasting longer than five minutes), ZENEO Midazolam. more

Technology

Cases of drug-resistant epilepsy are predicted to increase by more than 100,000 by the year 2026, according to data and analytics company, GlobalData. more

Analysis

Data, recently published in the journal Epilepsia, has demonstrated once-daily monotherapy, Zebinix (esclicarbazeptine acetate), is non-inferior to twice-daily controlled released carbamazepine in the treatment of newly diagnosed focal epilepsy more

News

Antiepileptic drugs and the potentially harmful effects on unborn children has hit the headlines as a survey reveals many women have not received the new safety warnings about the dangers of taking it during pregnancy. more

News

The European Medicines Agency (EMA) has approved Zebinix (eslicarbazepine acetate) for use as once-daily monotherapy to treat adults with newly-diagnosed partial-onset epilepsy. more

News

Laurus Synthesis and Epygenix Therapeutics have signed a collaboration agreement for the development and manufacture of EPX-100, an epilepsy candidate. more

News

Zebinix, an anti-epileptic drug which is used as an add-on therapy for adult patients with partial-onset seizures has been shown to reduce seizure frequency. more

News

The first 3D printed drug approved by the Food and Drug Administration (FDA) is now available for the treatment of epilepsy more

News

Epidiolex, a cannabis-based drug has been used to treat children with Dravet syndrome, a rare form of epilepsy, in GW Pharmaceutical’s (GW) phase three clinical study more

News

UCB’s Briviact (brivaracetam) has been authorised as an add-on treatment for partial onset seizures (POS) in adults with epilepsy and is now available on the NHS more

News

The first 3D printed drug has been approved by the American Food and Drug Administration (FDA) for the treatment of epilepsy more

News

Pfizer and Flynn Pharma stand accused of overcharging the NHS millions for an anti-epilepsy drug. more

News

The FDA has approved the first 3D printed drug, Aprecia Pharmaceuticals' Spritam. more

News